Cargando…

HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation

Mucosal surfaces account for the vast majority of HIV transmission. In adults, HIV transmission occurs mainly by vaginal and rectal routes but rarely via oral route. By contrast, pediatric HIV infections could be as the result of oral route by breastfeeding. As such mucosal surfaces play a crucial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Heron, Samantha E., Elahi, Shokrollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339276/
https://www.ncbi.nlm.nih.gov/pubmed/28326084
http://dx.doi.org/10.3389/fimmu.2017.00241
_version_ 1782512627547635712
author Heron, Samantha E.
Elahi, Shokrollah
author_facet Heron, Samantha E.
Elahi, Shokrollah
author_sort Heron, Samantha E.
collection PubMed
description Mucosal surfaces account for the vast majority of HIV transmission. In adults, HIV transmission occurs mainly by vaginal and rectal routes but rarely via oral route. By contrast, pediatric HIV infections could be as the result of oral route by breastfeeding. As such mucosal surfaces play a crucial role in HIV acquisition, and spread of the virus depends on its ability to cross a mucosal barrier. HIV selectively infects, depletes, and/or dysregulates multiple arms of the human immune system particularly at the mucosal sites and causes substantial irreversible damage to the mucosal barriers. This leads to microbial products translocation and subsequently hyper-immune activation. Although introduction of antiretroviral therapy (ART) has led to significant reduction in morbidity and mortality of HIV-infected patients, viral replication persists. As a result, antigen presence and immune activation are linked to “inflammaging” that attributes to a pro-inflammatory environment and the accelerated aging process in HIV patients. HIV infection is also associated with the prevalence of oral mucosal infections and dysregulation of oral microbiota, both of which may compromise the oral mucosal immunity of HIV-infected individuals. In addition, impaired oral immunity in HIV infection may predispose the patients to periodontal diseases that are associated with systemic inflammation and increased risk of cardiovascular diseases. The purpose of this review is to examine existing evidence regarding the role of innate and cellular components of the oral cavity in HIV infection and how HIV infection may drive systemic hyper-immune activation in these patients. We will also discuss current knowledge on HIV oral transmission, HIV immunosenescence in relation to the oral mucosal alterations during the course of HIV infection and periodontal disease. Finally, we discuss oral manifestations associated with HIV infection and how HIV infection and ART influence the oral microbiome. Therefore, unraveling how HIV compromises the integrity of the oral mucosal tissues and innate immune components of the oral cavity and its association with induction of chronic inflammation are critical for the development of effective preventive interventions and therapeutic strategies.
format Online
Article
Text
id pubmed-5339276
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53392762017-03-21 HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation Heron, Samantha E. Elahi, Shokrollah Front Immunol Immunology Mucosal surfaces account for the vast majority of HIV transmission. In adults, HIV transmission occurs mainly by vaginal and rectal routes but rarely via oral route. By contrast, pediatric HIV infections could be as the result of oral route by breastfeeding. As such mucosal surfaces play a crucial role in HIV acquisition, and spread of the virus depends on its ability to cross a mucosal barrier. HIV selectively infects, depletes, and/or dysregulates multiple arms of the human immune system particularly at the mucosal sites and causes substantial irreversible damage to the mucosal barriers. This leads to microbial products translocation and subsequently hyper-immune activation. Although introduction of antiretroviral therapy (ART) has led to significant reduction in morbidity and mortality of HIV-infected patients, viral replication persists. As a result, antigen presence and immune activation are linked to “inflammaging” that attributes to a pro-inflammatory environment and the accelerated aging process in HIV patients. HIV infection is also associated with the prevalence of oral mucosal infections and dysregulation of oral microbiota, both of which may compromise the oral mucosal immunity of HIV-infected individuals. In addition, impaired oral immunity in HIV infection may predispose the patients to periodontal diseases that are associated with systemic inflammation and increased risk of cardiovascular diseases. The purpose of this review is to examine existing evidence regarding the role of innate and cellular components of the oral cavity in HIV infection and how HIV infection may drive systemic hyper-immune activation in these patients. We will also discuss current knowledge on HIV oral transmission, HIV immunosenescence in relation to the oral mucosal alterations during the course of HIV infection and periodontal disease. Finally, we discuss oral manifestations associated with HIV infection and how HIV infection and ART influence the oral microbiome. Therefore, unraveling how HIV compromises the integrity of the oral mucosal tissues and innate immune components of the oral cavity and its association with induction of chronic inflammation are critical for the development of effective preventive interventions and therapeutic strategies. Frontiers Media S.A. 2017-03-07 /pmc/articles/PMC5339276/ /pubmed/28326084 http://dx.doi.org/10.3389/fimmu.2017.00241 Text en Copyright © 2017 Heron and Elahi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Heron, Samantha E.
Elahi, Shokrollah
HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title_full HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title_fullStr HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title_full_unstemmed HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title_short HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
title_sort hiv infection and compromised mucosal immunity: oral manifestations and systemic inflammation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339276/
https://www.ncbi.nlm.nih.gov/pubmed/28326084
http://dx.doi.org/10.3389/fimmu.2017.00241
work_keys_str_mv AT heronsamanthae hivinfectionandcompromisedmucosalimmunityoralmanifestationsandsystemicinflammation
AT elahishokrollah hivinfectionandcompromisedmucosalimmunityoralmanifestationsandsystemicinflammation